e-learning
resources
Paris 2018
Monday, 17.09.2018
CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Progression of Rheumatoid-arthritis associated interstitial lung disease by radiological subtype
S. Sukhmani (London, United Kingdom), K. Myall (London, United Kingdom), B. Lams (London, United Kingdom), S. Agarwal (London, United Kingdom), A. West (London, United Kingdom)
Source:
International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Session:
CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Session type:
Thematic Poster
Number:
2971
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Sukhmani (London, United Kingdom), K. Myall (London, United Kingdom), B. Lams (London, United Kingdom), S. Agarwal (London, United Kingdom), A. West (London, United Kingdom). Progression of Rheumatoid-arthritis associated interstitial lung disease by radiological subtype. 2971
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Clinical characteristics of patients with unclassifiable interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Prevalence and prognosis of unclassifiable interstitial lung disease
Source: Eur Respir J 2014; 43: 1529-1530
Year: 2014
Prevalence and prognosis of unclassifiable interstitial lung disease
Source: Eur Respir J 2013; 42: 750-757
Year: 2013
Unclassifiable interstitial lung disease: a distinct entity with heterogeneous progression
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
Pulmonary physiology is poorly associated with radiological extent of disease in systemic sclerosis-associated interstitial lung disease
Source: Eur Respir J, 53 (5) 1802182; 10.1183/13993003.02182-2018
Year: 2019
The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Interstitial lung disease associated with polymyositis-dermatomyositis
Source: Eur Respir J 2005; 26: Suppl. 49, 31s
Year: 2005
Familial pulmonary fibrosis: Clinical-functional and radiological features
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Clinical course and outcome of vasculitis related interstitial lung disease
Source: International Congress 2014 – ILDs 2
Year: 2014
Clinical characteristics of anti-Jo-1-positive interstitial lung disease
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Prevalence of progressive fibrosing interstitial lung disease
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
The prognostic factor in patients with myositis-associated interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept